BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Eurofins MWG Operon Quality Management System Achieves ISO 9001:2008 & ISO 13485:2003 Certification


9/9/2011 11:42:21 AM

Huntsville, Alabama, September 9, 2011. Eurofins MWG Operon, Inc. announces that its quality management system in the Huntsville, Alabama headquarters facility has achieved certification to two ISO standards by BSI Group America Inc. ISO 9001:2008 specifies requirements for a quality management system that consistently provides products and services that meet customer, statutory, and regulatory requirements. Certification to this standard demonstrates the commitment of Eurofins MWG Operon to enhancing customer satisfaction and continuously improving our processes.

ISO 13485:2003, specifies requirements for a quality management system that consistently provides medical devices and related services that meet customer and regulatory requirements specific to this industry.

“I am very proud that we have been awarded these certifications to demonstrate our commitment to the continuous improvement of our processes and to customer satisfaction,” stated Martin Kunz, CEO of Eurofins MWG Operon, Inc. “These certificates are also an important step in the expansion of Eurofins MWG Operon products and services beyond research use only applications and into the diagnostics market.”

The certificates can be viewed and downloaded at www.operon.com/company/certificates.aspx

About Eurofins MWG Operon

Eurofins MWG Operon, a member of the Eurofins Group with major offices and production facilities in the United States, Europe, and Asia, is an international provider of DNA sequencing services, DNA synthesis products, and bioinformatic services for academic and industrial research. The company’s strengths are its strong customer orientation, fast service, and high quality. For further information, please visit our website at: www.operon.com.

Contact Information:

Paul Brown

Head of Marketing



Read at BioSpace.com

Eurofins
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES